Results 271 to 280 of about 58,029 (309)

Intravenous tenecteplase compared with alteplase for acute ischaemic stroke in Canada (AcT): a pragmatic, multicentre, open-label, registry-linked, randomised, controlled, non-inferiority trial

Lancet, The, 2022
Dar Dowlatshahi, Thalia S Field, Michael D Hill   +2 more
exaly  

Robust IgM responses following intravenous vaccination with Bacille Calmette–Guérin associate with prevention of Mycobacterium tuberculosis infection in macaques

Nature Immunology, 2021
Edward B Irvine, Patricia A Darrah, Sally A Shin   +2 more
exaly  

Intravenous Immunoglobulins

2008
Doerte Bittner, Alexander Enk
openaire   +1 more source

Intravenous nanoparticle vaccination generates stem-like TCF1+ neoantigen-specific CD8+ T cells

Nature Immunology, 2020
Faezzah Baharom, Hidehiro Yamane, Charles-Antoine Dutertre   +2 more
exaly  

SAFETY OF INTRAVENOUS IMMUNOGLOBULIN

The Lancet, 1987
W L, Shaw, R R, Stewart
openaire   +2 more sources

Intravenous Immunoglobulin

JAMA, 1990
openaire   +1 more source

[Intravenous immunoglobulins].

Bulletin de l'Academie nationale de medecine, 2013
openaire   +3 more sources

Intravenous immunoglobulin therapy: how does IgG modulate the immune system?

Nature Reviews Immunology, 2013
Falk Nimmerjahn
exaly  

Intravenous Immunoglobulin

2015
Francisco Kerdel, Luis Dehesa
openaire   +1 more source

[Intravenous immunoglobulin therapy].

La Revue du praticien, 2005
Intravenous immunoglobulins (IVIg) are therapeutic preparations of normal human IgG that are obtained from pools of healthy blood donors. They can be used at low dose in the substitutive therapy of patients with primary or secondary immune deficiencies, or at high dose as an immunomodulatory agent in a large number of autoimmune and/or systemic ...
openaire   +1 more source